Goldman Sachs Raises Everest Medicines’ Target Price to HK$48.32 on Stronger Commercial and R&D Outlook
HONG KONG, Feb 19, 2025 - (ACN Newswire) - Goldman Sachs’ latest report on China’s biotechnology sector highlights Everest Medicines
HONG KONG, Feb 19, 2025 - (ACN Newswire) - Goldman Sachs’ latest report on China’s biotechnology sector highlights Everest Medicines
One in five older adults gets an infection up to six months after heart surgery — with women far more
If anyone's in position to make things happen, it's him...
Amazon’s golf section is underrated—and, best yet, it’s loaded with deals...
The weird ways that seeing your team win—or lose—might be aging you...
They’re stressful. They’re tough. They’re the OSCEs: Exams that train you — the medical student — to be the best
A postpartum intervention that prescheduled an annual primary care provider (PCP) appointment for pregnant participants increased their likelihood of visiting
A state lawmaker wants health insurers to disclose denial rates and explain those denials as anger grows over rising costs
States are required to claw back health care costs from the estates of many Medicaid recipients. Some, including Iowa, are
Pain MD, which once ran as many as 20 clinics across three states, gave chronic-pain patients about 700,000 total injections
No posts found.